This, in turn, can lead to a more favorable inflammatory profile, characterized by lower circulating levels of cytokines such as IL-6, TNF-α, and C-reactive protein (CRP)—all of which have been associated with poorer surgical outcomes and delayed recovery in CRC patients [168,169,170]. The gene discussed is CRP; the disease is colorectal carcinoma.